Novel benzofurane carbonyl analogs of donepezil as acetylcholinesterase inhibitors

dc.authorid0000-0002-5976-676X
dc.authorid0000-0003-1896-2729
dc.authorid0000-0001-6047-2796
dc.authorid0000-0002-0841-1299
dc.contributor.authorŞahin, Zafer
dc.contributor.authorBiltekin, Sevde Nur
dc.contributor.authorYurttaş, Leyla
dc.contributor.authorBerk, Barkın
dc.contributor.authorKüçükkılınç, Tuba Tüylü
dc.contributor.authorDemirayak, Şeref
dc.date.accessioned2022-05-20T09:06:43Z
dc.date.available2022-05-20T09:06:43Z
dc.date.issued2022
dc.departmentİstanbul Medipol Üniversitesi, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü, Farmasötik Kimya Ana Bilim Dalı
dc.departmentİstanbul Medipol Üniversitesi, Eczacılık Fakültesi, Temel Eczacılık Bilimleri Bölümü, Farmasötik Mikrobiyoloji Ana Bilim Dalı
dc.description.abstractDonepezil is the most prescribed drug for mild to moderate Alzheimer's Disease. There is not any alternative drug with this potency yet. New scaffolds bearing benzofurans and amines are being tested for good potency on acetylcholinesterase enzyme to mimic donepezil. In this study, we synthesized 22 novel compounds (2a-b, 3a-t) namely benzofuroyl-phenylpiperazines with 3 step reaction having one microwave green synthesis step at first. Compounds were tested with a modified Ellmann method on cholinesterases. Molecular modeling studies were performed on human acetylcholinesterase X-ray crystal structure complexed with donepezil (4EY7) using Maestro Schrödinger. The most active compounds were subjected to a ?-amyloid disaggregation assay. All tested compounds showed good activity (except 3n-p bearing Cl on benzofurane) on acetylcholinesterase (0.98–54 µM) and most of the compounds showed a one-digit IC50, where donepezil was 0.12 µM. The most active compounds according to IC50 values were 3t: 0.98 µM, 3s:1.07 µM, 2b:1.08 µM and 2a: 1.14 µM. Besides, compounds did not show significant activity on butyrylcholinesterase at 100 µM. Molecular modeling studies of compounds showed a good consistency (rmsd=0.45) with the binding mode and interactions of donepezil. 2b, 3 s and 3t exhibited good disaggregation potential on 1–40 ?-amyloid. Compound 3t disaggregated more than standard drug rifampicin. Cytotoxicity test results on HEK293 (at 50 µM), showed lower cytotoxicity (except for 3j-k) compared to cisplatin (46% viability). Promisingly, the most active compounds on AChE, 2a-b and 3q-t, showed the lowest cytotoxicity (64–74% viability). Consequently, we have developed potent inhibitors of AChE with close activity to donepezil. For enzyme activity; the presence of methoxy on the aromatic site, ionizable nitrogen group and a carbonyl group on/nearly to main ring (benzofurane) asserted essentially to develop more potent compounds that are equivalent to donepezil.
dc.identifier.citationŞahin, Z., Biltekin, S. N., Yurttaş, L., Berk, B., Küçükkılınç, T. T. ve Demirayak, Ş. (2022). Novel benzofurane carbonyl analogs of donepezil as acetylcholinesterase inhibitors. Journal of Molecular Structure, 1264. https://doi.org/10.1016/j.molstruc.2022.133193
dc.identifier.doi10.1016/j.molstruc.2022.133193
dc.identifier.issn0022-2860
dc.identifier.issn1872-8014
dc.identifier.scopus2-s2.0-85129473157
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1016/j.molstruc.2022.133193
dc.identifier.urihttps://hdl.handle.net/20.500.12511/9453
dc.identifier.volume1264
dc.identifier.wos000805635400001en_US
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.institutionauthorŞahin, Zafer
dc.institutionauthorBiltekin, Sevde Nur
dc.institutionauthorBerk, Barkın
dc.institutionauthorDemirayak, Şeref
dc.language.isoen
dc.publisherElsevier B.V.
dc.relation.ispartofJournal of Molecular Structureen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectAcetylcholinesterase
dc.subjectAlzheimer
dc.subjectBenzofurane
dc.subjectDonepezil
dc.subjectEnzyme
dc.titleNovel benzofurane carbonyl analogs of donepezil as acetylcholinesterase inhibitors
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Şahin-Zafer-2022.pdf
Boyut:
1.37 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: